Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)

NCT02560389 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT02560389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02560389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
May 1, 2018
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stress disorder, post traumatic